SAN DIEGO--(BUSINESS WIRE)--n-Lorem, a nonprofit foundation, announced today that it will hold its third annual Nano-rare Patient Colloquium in Cambridge, Mass., where n-Lorem leaders and experts in ...
-- Research, supported by the Wolverine Foundation and published in JCI Insights, characterizes a mutation in MAPK8IP3 that disrupts dopamine signaling SAN DIEGO--(BUSINESS WIRE)--May 08, 2025-- ...
Demand from the nano-rare community has been overwhelming, n-Lorem has filed more than 25 INDs that support the treatment of more than 30 patients n-Lorem continues to seek additional financial ...
PALO ALTO, Calif. & SAN DIEGO--(BUSINESS WIRE)--n-Lorem, a nonprofit foundation, and GondolaBio, a clinical-stage biotechnology company founded in 2024 and dedicated to developing novel medicines for ...
MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced plans to pursue a strategic collaboration ...
n-Lorem, a nonprofit foundation, announced today that it will hold its third annual Nano-rare Patient Colloquium in Cambridge, Mass., where n-Lorem leaders and experts in the field will share updates ...